Plasma preparation to measure FDA-approved protein markers by selected reaction monitoring

BACKGROUND: The development of commercially available panels for human blood plasma screening via selected reaction monitoring (SRM) offers reliable, cost-efficient and highly-standardized discovery and validation of protein biomarkers. However, protein detection by SRM can be hampered by interferin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiseleva, Olga I., Romashova, Yulia A., Moskaleva, Natalia E., Petushkova, Natalia A., Teryaeva, Nadezhda B., Belyaev, Artem Yu., Lisitsa, Andrey V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607682/
https://www.ncbi.nlm.nih.gov/pubmed/26471814
http://dx.doi.org/10.1186/s40169-015-0071-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607682/
https://www.ncbi.nlm.nih.gov/pubmed/26471814
http://dx.doi.org/10.1186/s40169-015-0071-4

Ejemplares similares